Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Der Nervenarzt|June 10, 2017
[Shared decision-making in acute psychiatric medicine : Contraindication or a challenge?]S Heres, J HamannEuropean Psychiatry : the Journal of the Association of European Psychiatrists|December 3, 2014
Treatment of early episode in patients with schizophrenia: the role of long acting antipsychoticsS Heres, M Lambert, R VauthDer Nervenarzt|October 18, 2011
[Considerations about the efficacy of psychopharmacological drugs]S Leucht, S Heres, J M DavisEpidemiology and Psychiatric Sciences|May 23, 2020
Caregiver involvement in psychiatric inpatient treatment - a representative survey among triads of patients, caregivers and hospital psychiatristsF Schuster, F Holzhüter, S Heres, et al.The Pharmacogenomics Journal|March 12, 2008
DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gainJ Popp, S Leucht, S Heres, et al.The Pharmacogenomics Journal|May 20, 2009
Intermediate metabolizer: increased side effects in psychoactive drug therapy. The key to cost-effectiveness of pretreatment CYP2D6 screening?B Laika, S Leucht, S Heres, et al.Fortschritte Der Neurologie-Psychiatrie|May 25, 2013
Pharmacological treatment of schizophreniaS Leucht, S Heres, W Kissling, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|June 16, 2004
Language bias in neuroscience--is the Tower of Babel located in Germany?S Heres, S Wagenpfeil, J Hamann, et al.The Pharmacogenomics Journal|July 29, 2009
Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcomeB Laika, S Leucht, S Heres, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|June 24, 2010
Psychiatrists' attitude to antipsychotic depot treatment in patients with first-episode schizophreniaS Heres, T Reichhart, J Hamann, et al.Pageof 2